Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126363771 | 12636377 | 1 | I | 201403 | 20160502 | 20160809 | 20160809 | EXP | US-BAYER-2016-090057 | BAYER | 85.00 | YR | E | F | Y | 0.00000 | 20160809 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126363771 | 12636377 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | |||||
126363771 | 12636377 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | |||||
126363771 | 12636377 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Y | 0 | FILM-COATED TABLET | ||||||||||
126363771 | 12636377 | 4 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | 81 MG, UNK | Y | 999999 | 81 | MG | CHEWABLE TABLET | |||||||
126363771 | 12636377 | 5 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, UNK | Y | 0 | 75 | MG | |||||||
126363771 | 12636377 | 6 | C | ASCORBIC ACID. | ASCORBIC ACID | 1 | Unknown | UNK | 0 | ||||||||||
126363771 | 12636377 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
126363771 | 12636377 | 8 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | UNK | 0 | ||||||||||
126363771 | 12636377 | 9 | C | COLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | UNK | 0 | ||||||||||
126363771 | 12636377 | 10 | C | DABIGATRAN | DABIGATRAN | 1 | Unknown | UNK | 0 | ||||||||||
126363771 | 12636377 | 11 | C | POLYETHYLENE GLYCOL | POLYETHYLENE GLYCOLS | 1 | Unknown | UNK | 0 | ||||||||||
126363771 | 12636377 | 12 | C | SOLIFENACIN | SOLIFENACIN | 1 | Unknown | UNK | 0 | ||||||||||
126363771 | 12636377 | 13 | C | CALCIUM | CALCIUM | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126363771 | 12636377 | 1 | Thrombosis prophylaxis |
126363771 | 12636377 | 2 | Cerebrovascular accident prophylaxis |
126363771 | 12636377 | 3 | Atrial fibrillation |
126363771 | 12636377 | 4 | Product used for unknown indication |
126363771 | 12636377 | 5 | Product used for unknown indication |
126363771 | 12636377 | 6 | Product used for unknown indication |
126363771 | 12636377 | 7 | Product used for unknown indication |
126363771 | 12636377 | 8 | Product used for unknown indication |
126363771 | 12636377 | 9 | Product used for unknown indication |
126363771 | 12636377 | 10 | Product used for unknown indication |
126363771 | 12636377 | 11 | Product used for unknown indication |
126363771 | 12636377 | 12 | Product used for unknown indication |
126363771 | 12636377 | 13 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126363771 | 12636377 | HO |
126363771 | 12636377 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126363771 | 12636377 | Cardiac disorder | |
126363771 | 12636377 | Fall | |
126363771 | 12636377 | Haemorrhagic diathesis | |
126363771 | 12636377 | Internal haemorrhage | |
126363771 | 12636377 | Subdural haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126363771 | 12636377 | 1 | 20010605 | 0 | ||
126363771 | 12636377 | 2 | 20131227 | 201403 | 0 | |
126363771 | 12636377 | 4 | 201406 | 0 | ||
126363771 | 12636377 | 5 | 201406 | 0 |